Trulieve Cannabis (TRLV) EBIT (2020 - 2026)
Trulieve Cannabis (TRLV) posted quarterly EBIT of $35.7 million for Q1 2026, up 7.2% year-over-year from $33.3 million in Q1 2025, and up 133.54% quarter-over-quarter from $15.3 million in Q4 2025.
Trulieve Cannabis (TRLV) EBIT (2020 - 2026) Analysis & Trends
Trulieve Cannabis' EBIT history runs 7 years deep, the most recent figure standing at $35.7 million for Q1 2026.
- In Q1 2026, EBIT rose 7.2% year-over-year to $35.7 million; the TTM figure through Mar 2026 stood at $145.9 million (up 71.63% YoY), while the FY2025 annual figure was $143.5 million, up 46.75% from the prior year.
- EBIT for Q1 2026 stood at $35.7 million, up from $15.3 million in the prior quarter.
- The five-year high for EBIT was $52.6 million in Q2 2025, with the low at -$291.3 million in Q2 2023.
- The 5-year median for EBIT is $29.2 million (2022), against an average of $6.1 million.
- The sharpest annual moves came in 2023 and 2025: EBIT tumbled 802.35% in 2023, then jumped 6734.63% in 2025.
- Trulieve Cannabis' EBIT stood at $5.2 million in 2022, then surged by 460.51% to $29.2 million in 2023, then slumped by 95.52% to $1.3 million in 2024, then surged by 1069.5% to $15.3 million in 2025, then surged by 133.54% to $35.7 million in 2026.
- Business Quant data shows TRLV's EBIT at $35.7 million in Q1 2026, $15.3 million in Q4 2025, and $42.2 million in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -370.52 Mn |
| Mar 31, 2026 | 35.73 Mn |
| Dec 31, 2025 | 15.30 Mn |
| Sep 30, 2025 | 42.24 Mn |
| Jun 30, 2025 | 52.63 Mn |
| Mar 31, 2025 | 33.33 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 618,000.00 |
| Jun 30, 2024 | 49.75 Mn |
| Mar 31, 2024 | 46.10 Mn |
| Dec 31, 2023 | 29.18 Mn |
| Sep 30, 2023 | 23.34 Mn |
| Jun 30, 2023 | -291.29 Mn |
| Mar 31, 2023 | 17.15 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Sep 30, 2022 | -27.34 Mn |
| Jun 30, 2022 | 41.47 Mn |
| Mar 31, 2022 | 29.17 Mn |
| Dec 31, 2021 | -11.09 Mn |
| Sep 30, 2021 | 66.28 Mn |